1. Chen, Sisi, Geng, Xinwei, Syeda, Madiha Zahra, Zhang, Chao, Ying, Songmin. 2021. Human MUS81: A Fence-Sitter in Cancer. In Frontiers in cell and developmental biology, 9, 657305. doi:10.3389/fcell.2021.657305. https://pubmed.ncbi.nlm.nih.gov/33791310/
2. Li, Chengguo, Shen, Qian, Zhang, Peng, Yin, Yuping, Tao, Kaixiong. 2021. Targeting MUS81 promotes the anticancer effect of WEE1 inhibitor and immune checkpoint blocking combination therapy via activating cGAS/STING signaling in gastric cancer cells. In Journal of experimental & clinical cancer research : CR, 40, 315. doi:10.1186/s13046-021-02120-4. https://pubmed.ncbi.nlm.nih.gov/34625086/
3. Xing, Meichun, Wang, Xiaohui, Palmai-Pallag, Timea, Hickson, Ian D, Ying, Songmin. . Acute MUS81 depletion leads to replication fork slowing and a constitutive DNA damage response. In Oncotarget, 6, 37638-46. doi:10.18632/oncotarget.5497. https://pubmed.ncbi.nlm.nih.gov/26415217/
4. Zhang, Yan, Shi, Duo, Zhang, Xing, Liu, Wen, Luo, Bing. . Downregulation of MUS81 expression inhibits cell migration and maintains EBV latent infection through miR-BART9-5p in EBV-associated gastric cancer. In Journal of medical virology, 95, e28725. doi:10.1002/jmv.28725. https://pubmed.ncbi.nlm.nih.gov/37185865/
5. Coelho, Ricardo, Tozzi, Alessandra, Disler, Muriel, Jacob, Francis, Heinzelmann-Schwarz, Viola. 2022. Overlapping gene dependencies for PARP inhibitors and carboplatin response identified by functional CRISPR-Cas9 screening in ovarian cancer. In Cell death & disease, 13, 909. doi:10.1038/s41419-022-05347-x. https://pubmed.ncbi.nlm.nih.gov/36307400/
6. Lu, Renquan, Xie, Suhong, Wang, Yanchun, Shammas, Masood A, Guo, Lin. 2019. MUS81 Participates in the Progression of Serous Ovarian Cancer Associated With Dysfunctional DNA Repair System. In Frontiers in oncology, 9, 1189. doi:10.3389/fonc.2019.01189. https://pubmed.ncbi.nlm.nih.gov/31803609/
7. Wu, Fan, Li, Ting-Yue, Su, Shu-Chao, Liu, Jian-Wei, Wang, Bai-Lin. 2016. STC2 as a novel mediator for Mus81-dependent proliferation and survival in hepatocellular carcinoma. In Cancer letters, 388, 177-186. doi:10.1016/j.canlet.2016.11.039. https://pubmed.ncbi.nlm.nih.gov/27939696/
8. Wu, Fan, Shirahata, Atsushi, Sakuraba, Kazuma, Sanada, Yutaka, Hibi, Kenji. 2010. Downregulation of Mus81 as a novel prognostic biomarker for patients with colorectal carcinoma. In Cancer science, 102, 472-7. doi:10.1111/j.1349-7006.2010.01790.x. https://pubmed.ncbi.nlm.nih.gov/21175991/
智鼠故事 
